SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001679082-19-000034
Filing Date
2019-11-12
Accepted
2019-11-12 08:40:44
Documents
16
Period of Report
2019-11-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-kq2september302019m.htm   iXBRL 8-K 53834
2 EXHIBIT 99.1 a9302019myovantex991.htm EX-99.1 123293
8 myovant15.jpg GRAPHIC 14626
  Complete submission text file 0001679082-19-000034.txt   360469

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT myov-20191101.xsd EX-101.SCH 4567
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT myov-20191101_cal.xml EX-101.CAL 610
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT myov-20191101_def.xml EX-101.DEF 1460
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT myov-20191101_lab.xml EX-101.LAB 28168
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT myov-20191101_pre.xml EX-101.PRE 14574
14 EXTRACTED XBRL INSTANCE DOCUMENT a8-kq2september302019m_htm.xml XML 4634
Mailing Address SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE LONDON X0 SW1Y 4LB
Business Address SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE LONDON X0 SW1Y 4LB 44(0)207 400 3347
Myovant Sciences Ltd. (Filer) CIK: 0001679082 (see all company filings)

IRS No.: 000000000 | State of Incorp.: CA | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-37929 | Film No.: 191206390
SIC: 2834 Pharmaceutical Preparations